who we are?
Math Biology is an innovative Italian deep-tech SME pioneering advancements in health technology.
At Math Biology, we believe health shouldn’t be something that happens to you, it should be something you shape. Our mission is to move human health from reaction to intention, giving people the power to understand their bodies, unlock their full potential and live longer, fuller lives.
We envision a future where everyone has the insight to act before illness strikes, where prevention isn’t a privilege, but a birthright, made possible through precision, personalization and the power of data.
The minds behind Math Biology
Our team combines expertise from big pharma, the AI industry and academia, alongside a track record of entrepreneurial success, including seasoned managers and partners supported by a group of dynamic young researchers.
Giuseppe Sgro
Co-Founder, R&D Director
Biologist and researcher with many years of experience in various international pharmaceutical companies and deep knowledge of metabolic processes.
For over ten years, Giuseppe worked collecting data and designing protocols to identify the Metabolic profile of people suffering from various disorders. This crucial activity is a pillar of the Math Biology innovation.
Raffaele Maccioni
Co-Founder, CEO & CTO
Graduated from Polytechnic of Milano, has over 25 years of experience applying mathematical optimization / artificial intelligence systems to complex processes. Raffaele obtained the prestigious international recognition, in the context of the application of decision sciences, called Franz Edelman, promoted by the American association Informs. Entrepreneur and Founder of ACT Operations Research, an Innovative SME that developed software technologies in decision science. ACT Operations Research thank to an M&A operation, is now part of the Spindox Group, and Raffaele became an Equity Partner in the Group
Alessandro Cascia
CFO & Partner
A degree in statistics and has forged a brilliant career in finance, particularly with the Azimut Group. Passionate about Real Economy and Venture Capital. CEO of 2 SPVs and CFO of 2 Startups, he has extensive knowledge of institutional and private investors, specialized in investments and asset management.
Franscesca A. Aiello
R&D Coordinator, Postdoctoral Researcher in Molecular Biology, Biochemistry and Metabolism
Francesca Antonella Aiello, PhD in Human Biology and Medical Genetics, specializes in scientific writing and research involving DMA technology, which is constantly updated to reflect the latest biomolecular knowledge of metabolic processes. Her expertise was developed during her PhD and post-doctoral work at leading research centers in Italy and abroad, focusing on specific diseases. As a registered Biologist, she applies and advances DMA to keep it aligned with current scientific advancements.
Maria Cristina Caracciolo
Legal & Corporate Affairs
Maria Cristina Caracciolo is a lawyer and works as legal consultant for industrial Companies. She obtained a Ph.D. in comparative and International Law. She is used to support the management of the Companies she collaborate with regarding not only legal issues but also strategic solution to be adopted. In her activity she drafts and reviews all the legal documentation of the Company, Contract of any type and Minutes.
emanuele carpanzano
Scientific Advisors PhD Univ. SUPSI
Emanuele Carpanzano is Director of Research, Development and Knowledge Transfer at the University of Applied Sciences and Arts of Southern Switzerland. He managed numerous R&D initiatives at international, national and regional level, as well as industrial research and knowledge transfer projects. He is active in different federal and international associations and institutions dedicated to education, research and innovation programs and initiatives.
Maddalena Mazzali
Marketing & Community Director
Maddalena Mazzali collaborates with organizations as a specialist in digital marketing, focusing on developing strategies that foster sustainable growth through effective communication design, strategic dissemination and engaging stakeholders. Within the intricate framework of making emerging technologies accessible to individuals, inclusivity stands at the core of Maddalena’s approach. By fostering understanding, she strives to make the world of innovation open and approachable, ensuring everyone can engage with and comprehend the transformative power of technology.
LuCa evangelisti
Biomolecular & Bioclinical Researcher, Biologist & Nutritionist
Former International & Italian Champion in Canoe Sprint, specialized in Sports Nutrition, Exercise Physiology & Sports Metabolomics.
IDA PAVESE
Oncologist – Specialist Advisor
Raffaele cerulli
Scientific Advisor PhD Univ. Salerno
Raffaele Cerulli is a full professor of Operations Research in the Department of Mathematics at the University of Salerno. Raffaele covers the position of Director of the Department of Mathematics at the University of Salerno and is a member of the scientific committee of UMI (Italian Mathematical Union). Raffaele is also a Board Member of the Italian Association for Operations Research (AIRO), covering the role of President of AIRO since January 2024.
Ted Matwijec
US Market Advisor
alessia stefanelli
Postdoctoral Researcher
ROBERTA NOCERINO
Postdoctoral Researcher
Giampiero bartolomei
Bioengineer Specialist & Researcher
Step by step toward a unified health ecosystem.
March 2026
Presented at the Future of Preventive Medicine & Public Health Conference in Rome, demonstrating how DMA® technology detects metabolic dysfunctions before symptoms appear.
February 2026
Presented Math Biology’s physiology-driven diagnostic platform at Health Summit Qatar, highlighting the role of AI and bioelectrical signals in preventive medicine.
Showcased DMA® technology at World Health Expo Dubai 2026, engaging with global healthcare leaders and innovation partners.
Invited to speak at ViVE Europe 2026 in Las Vegas, presenting the future of non-invasive, AI-powered predictive healthcare.
May 2025
Took part in Sanidays with exclusive Open Days featuring in-depth bio-cellular check-ups.
April 8–10, 2025
Joined the Italian-American Business Forum in New York, connecting with industry leaders and investors.
March 27–28, 2025
Showcased innovation at eMerge Americas 2025 in Miami, Florida.
January 27–30, 2025
Kicked off the year at Arab Health in Dubai, presenting DMA® to a global MedTech audience.
Winter/Spring 2025
MathBiology was selected for the U.S. Market Gateway Accelerator for BioSciences and MedTech in Philadelphia
November 6–8, 2024
Join Math Biology at MedTech World Malta in Valletta, connecting with global leaders in health innovation.
October 2024
Took part in top global health tech events including Rome Future Week, North Star Dubai, Frontiers Health Global Conference in Berlin, and MedTech World in Malta.
September 2024
Crowned winner of the Unicorn Jam Session Startup Battle during Rome Future Week — an initiative by the Impresapiens Research Center in partnership with Seedble and supported by Sapienza University.
Partnered with Circklo to accelerate expansion into the UK market.
July 2024
Opened our first Institutes of Human Biology in Rome and Salerno, establishing our operational base and refining the service delivery model.
May 2024
Selected as one of 15 startups for the Innovit Acceleration Program, gaining direct access to Silicon Valley’s innovation ecosystem and investor network.
April 2024
Successfully passed the evaluation phase of the Smart&Start funding program, securing support for our scale-up strategy.
March 2024
Awarded first place at the Battle Startup in Healthcare, hosted by Paideia Hospital International and Mater Dei.
October 2023
We secured funding for the 30-month PREVEDO project to improve AI-driven predictions of treatment outcomes for oncology and cardiovascular patients using our DMA Technology.
April 2023
Patent submitted.
December 2022
Achieved Electromagnetic Compatibility (EMC) Certification, validating compliance with international safety and performance standards.
August 2022
Launched the certification process for the DMA® Industrial Edition 1, marking a step toward large-scale deployment.
June 2022
Finalized the design of the industrial version of the DMA® biosensor, readying it for production and regulatory approval.
May 2022
Completed successful testing of biosensors and electronic devices 3.0, confirming improvements in accuracy and integration.
April 2022
Concluded the design of a secure cloud-to-edge IT infrastructure, enabling safe, scalable data management across multiple DMA® biosensors.
February 2022
Finished testing of biosensors and electronic devices 2.0, a key phase in the technology’s evolution.
January 2022
Launched a new PhD research collaboration with the Department of Mathematics at the University of Salerno, strengthening the scientific foundation of the project.
December 2021
Capital investment for 3200.000 € finalized.
September 2021
R&D activities stage 1 completed to produce the first Health Deep Screening Technology bio-sensor prototype.
May 2021
MISTER CNR Consortium join the Math Biology® empowering Math Biology R&D and design capabilities.
Math Biology® was founded.
Together, we made it possible
